MedPlus Health Services completes director tenures on June 10

MedPlus Health Services Limited announced the completion of the tenures of Mr. Madhavan Ganesan and Mr. Murali Sivaraman as Non-Executive Independent Directors on June 10, 2026. Both directors ceased to hold their positions at the end of business hours on June 10, 2026, following the conclusion of their first term with the company. The Board of Directors and management expressed their appreciation for the contributions made by the directors during their tenure.

The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation references a Master Circular dated January 30, 2026, regarding the details of the cessation. The company confirmed that the information is available on its website and the portals of BSE Limited and National Stock Exchange of India Limited.

Details of Cessation

The following table outlines the particulars regarding the change in directorship as per the regulatory filing:

Particulars	Mr. Madhavan Ganesan (DIN: 01674529)	Mr. Murali Sivaraman (DIN: 01461231)
Reason for Change	Completion of first tenure as an Independent Director of the Company.	Completion of first tenure as an Independent Director of the Company.
Date of Cessation	June 10, 2026 (Closing of Business hours)	June 10, 2026 (Closing of Business hours)
Brief Profile	NA	NA
Disclosure of relationships	NA	NA

The filing was signed by Gangadi Madhukar Reddy, Managing Director and Chief Executive Officer of MedPlus Health Services Limited.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.70%	+2.68%	+0.71%	+8.06%	-0.67%	-21.34%

MedPlus Health Services Limited disclosed on April 07, 2026, that its promoters have not created any new encumbrances on their shareholdings during the quarter ended March 31, 2026. The declarations were submitted in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. This disclosure assures investors that the promoter group's shareholding remains free from additional charges or pledges beyond those previously reported in the financial year.

The declarations were received from three key promoter entities: Gangadi Madhukar Reddy, Agilemed Investments Private Limited, and Lone Furrow Investments Private Limited. Each entity confirmed that no direct or indirect encumbrances were established on the shares held by them during the specified period. The only encumbrances in effect are those that had already been disclosed to the exchanges during the Financial Year 2025-26.

Promoter Declarations

The following table details the promoters who submitted the declarations for the period ended March 31, 2026:

Promoter Name	Status
Gangadi Madhukar Reddy	No new encumbrances
Agilemed Investments Private Limited	No new encumbrances
Lone Furrow Investments Private Limited	No new encumbrances

The confirmations were addressed to the Audit Committee of MedPlus Health Services Limited and subsequently forwarded to BSE Limited and National Stock Exchange of India Limited. Manoj Kumar Srivastava, Company Secretary & Compliance Officer, filed the intimation on behalf of the company.